{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:07:47Z","timestamp":1793430467031,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.annepidem.2020.03.011","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T20:41:35Z","timestamp":1585946495000},"page":"12-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992\u20132013"],"prefix":"10.1016","volume":"45","author":[{"given":"Leslie D.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umedjon","family":"Ibragimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Tempalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Stall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Satcher Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoshen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.F.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2020.03.011_bib1","volume":"vol. 28","year":"2017"},{"key":"10.1016\/j.annepidem.2020.03.011_bib2","series-title":"Morbidity and Mortality Weekly Report","article-title":"HIV infection and risk, prevention, and testing behaviors among injecting drug users\u2014National HIV Behavioral Surveillance System, 20 US cities","year":"2009"},{"key":"10.1016\/j.annepidem.2020.03.011_bib3","series-title":"HIV Surveillance Report","article-title":"HIV infection, risk, prevention, and testing behaviors among persons who inject drugs\u2014National HIV Behavioral Surveillance: injection drug use, 20 U.S. Cities","year":"2015"},{"key":"10.1016\/j.annepidem.2020.03.011_bib4","series-title":"HIV Surveillance Report","article-title":"HIV infection, risk, prevention, and testing behaviors among persons who inject drugs\u2014National HIV Behavioral Surveillance: injection drug use, 20 U.S. Cities","year":"2018"},{"key":"10.1016\/j.annepidem.2020.03.011_bib5","first-page":"90","article-title":"HIV transmission and injection drug use: lessons from the Indiana outbreak","volume":"24","author":"Janowicz","year":"2016","journal-title":"Top Antivir Med"},{"issue":"3","key":"10.1016\/j.annepidem.2020.03.011_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annepidem.2020.03.011_bib7","series-title":"The Enquirer","article-title":"CDC to help find roots of HIV \u2018cluster\u2019 tied to heroin, IV drugs in Campbell, Kenton counties","author":"DeMio","year":"2018"},{"key":"10.1016\/j.annepidem.2020.03.011_bib8","series-title":"Clinical advisory. HIV transmission through injection drug use","year":"2017"},{"key":"10.1016\/j.annepidem.2020.03.011_bib9","series-title":"Opioid crisis fuels a spike in HIV infections, and experts fear there's more to come","author":"Schumaker","year":"2018"},{"issue":"7","key":"10.1016\/j.annepidem.2020.03.011_bib10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s10461-011-9992-0","article-title":"Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areas","volume":"15","author":"Chatterjee","year":"2011","journal-title":"AIDS Behav"},{"issue":"5","key":"10.1016\/j.annepidem.2020.03.011_bib11","doi-asserted-by":"crossref","first-page":"e97596","DOI":"10.1371\/journal.pone.0097596","article-title":"Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections","volume":"9","author":"Lansky","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.annepidem.2020.03.011_bib12","series-title":"Fact sheet: HIV and people who inject drugs","year":"2018"},{"key":"10.1016\/j.annepidem.2020.03.011_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugpo.2007.11.011","article-title":"Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug","volume":"19","author":"Tempalski","year":"2008","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annepidem.2020.03.011_bib14","first-page":"1","article-title":"Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007","volume":"13","author":"Tempalski","year":"2018","journal-title":"Subst Abuse Treat Prevent Policy"},{"key":"10.1016\/j.annepidem.2020.03.011_bib15","series-title":"HIV and injection drug use. Syringe services programs for HIV prevention","year":"2016"},{"issue":"5","key":"10.1016\/j.annepidem.2020.03.011_bib16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2105\/AJPH.86.5.642","article-title":"The estimated prevalence and incidence of HIV in 96 large US metropolitan areas","volume":"86","author":"Holmberg","year":"1996","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.annepidem.2020.03.011_bib17","first-page":"434","article-title":"HIV among injection drug users in large US metropolitan areas, 1998","volume":"82","author":"Friedman","year":"2005","journal-title":"J\u00a0Urban Health"},{"issue":"1","key":"10.1016\/j.annepidem.2020.03.011_bib18","first-page":"132","article-title":"HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992\u20132002","volume":"86","author":"Tempalski","year":"2009","journal-title":"J\u00a0Urban Health"},{"issue":"3","key":"10.1016\/j.annepidem.2020.03.011_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","article-title":"County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States","volume":"73","author":"Van Handel","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.annepidem.2020.03.011_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.aids.0000196176.65551.a3","article-title":"Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas","volume":"20","author":"Friedman","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.annepidem.2020.03.011_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugpo.2016.03.003","article-title":"Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of research","volume":"32","author":"Friedman","year":"2016","journal-title":"Int J Drug Policy"},{"issue":"4","key":"10.1016\/j.annepidem.2020.03.011_bib22","doi-asserted-by":"crossref","first-page":"e0122367","DOI":"10.1371\/journal.pone.0122367","article-title":"National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in Europe: A panel data analysis","volume":"10","author":"Nikolopoulos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.annepidem.2020.03.011_bib23","series-title":"Results from the 2013 National Survey on Drug Use and Health: summary of national findings","year":"2014"},{"key":"10.1016\/j.annepidem.2020.03.011_bib24","series-title":"Key substance use and mental health indicators in the United States: results from the 2016 National Survey on Drug Use and Health","year":"2017"},{"issue":"3","key":"10.1016\/j.annepidem.2020.03.011_bib25","first-page":"377","article-title":"Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users","volume":"81","author":"Friedman","year":"2004","journal-title":"J\u00a0Urban Health"},{"issue":"6","key":"10.1016\/j.annepidem.2020.03.011_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.drugpo.2006.10.004","article-title":"Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America","volume":"18","author":"Friedman","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annepidem.2020.03.011_bib27","series-title":"HIV epidemiology: models and methods","first-page":"137","article-title":"Seroprevalence, seroconversion, and the history of the HIV epidemic among drug injectors","author":"Friedman","year":"1994"},{"issue":"47","key":"10.1016\/j.annepidem.2020.03.011_bib28","first-page":"1113","article-title":"Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV \u2013 United States, 2011","volume":"63","author":"Bradley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"04","key":"10.1016\/j.annepidem.2020.03.011_bib30","first-page":"81","article-title":"Mortality among Blacks or African Americans with HIV infection \u2013 United States, 2008-2012","volume":"64","author":"Siddiqi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annepidem.2020.03.011_bib31","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/00002030-199412000-00013","article-title":"Death from suicide and overdose among drug injectors after disclosure of first HIV test result","volume":"8","author":"van Haastrecht","year":"1994","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.annepidem.2020.03.011_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAI.0b013e31815d2f59","article-title":"Risk of hepatitis-related mortality increased among hepatitis C virus\/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study","volume":"47","author":"Smit","year":"2008","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.annepidem.2020.03.011_bib33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/01.qai.0000194234.31078.bf","article-title":"Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in reource-limited settings","volume":"41","author":"Abbas","year":"2006","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.annepidem.2020.03.011_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10461-005-9000-7","article-title":"Housing status and HIV risk behaviors: implications for prevention and policy","volume":"9","author":"Aidala","year":"2005","journal-title":"AIDS Behav"},{"issue":"3","key":"10.1016\/j.annepidem.2020.03.011_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.drugalcdep.2013.03.009","article-title":"The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD","volume":"132","author":"Linton","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.annepidem.2020.03.011_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10826080802344823","article-title":"The relationship between housing status and HIV risk among active drug users: a qualitative analysis","volume":"44","author":"Dickson-Gomez","year":"2009","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.annepidem.2020.03.011_bib37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2105\/AJPH.2013.301656","article-title":"Homelessness and other risk factors for HIV infection in the current outbreak among injection drug users in Athens, Greece","volume":"105","author":"Sypsa","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annepidem.2020.03.011_bib38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3109\/10826084.2015.978659","article-title":"Big events in Greece and HIV infection among people who inject drugs","volume":"50","author":"Nikolopoulos","year":"2015","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.annepidem.2020.03.011_bib39","series-title":"What is \u2018Ending the HIV Epidemic: A Plan for America?\u201d","year":"2020"},{"issue":"4","key":"10.1016\/j.annepidem.2020.03.011_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QAD.0b013e32834f19b6","article-title":"HIV infection and risk of overdose: a systematic review and meta-analysis","volume":"26","author":"Green","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.annepidem.2020.03.011_bib42","unstructured":"Centers for Disease Control and Prevention. National HIV Prevention Monitoring and Evaluation data (CDC NHM&E) 1992-2013. Division of HIV\/AIDS Prevention. National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention."},{"key":"10.1016\/j.annepidem.2020.03.011_bib43","unstructured":"Centers for Disease Control and Prevention. Expanded Testing Program Initiative (ETP) data 2008-2013.Division of HIV\/AIDS Prevention. National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention."},{"key":"10.1016\/j.annepidem.2020.03.011_bib44","unstructured":"Centers for Disease Control and Prevention. National HIV Surveillance System data (1992-2017). Division of HIV\/AIDS Prevention. National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention."},{"key":"10.1016\/j.annepidem.2020.03.011_bib45","unstructured":"Centers for Disease Control and Prevention. National HIV Behavioral Surveillance data (2017). Division of HIV\/AIDS Prevention, National Center for HIV\/AIDS, Viral Hepatitis, Sexual Transmitted Diseases and Tuberculosis Prevention."},{"key":"10.1016\/j.annepidem.2020.03.011_bib46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2105\/AJPH.86.5.642","article-title":"The estimated prevalence and incidence of HIV in 96 large US metropolitan areas: Supplementary Material","volume":"86","author":"Holmberg","year":"1996","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annepidem.2020.03.011_bib47","unstructured":"U.S. Census Bureau. Census 1990, 2000, 2010 Census, and 2013 Population Estimates.https:\/\/www.census.gov\/programs-surveys\/popest\/data\/tables.html[Accessed 15 March 2017]"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279720301423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279720301423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:25:05Z","timestamp":1760927105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279720301423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":45,"alternative-id":["S1047279720301423"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2020.03.011","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992\u20132013","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2020.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}